Endeavour Medtech Growth II LP 13D/13G Filings for

Endeavour Medtech Growth II LP 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-08-27
9:28 pm
Purchase
2021-07-14 13G Rapid Micro Biosystems, Inc.
RPID
Endeavour Medtech Growth II LP 2,043,635
6.000%
2,043,635increase
(New Position)
Filing